← Back to Clinical Trials
Recruiting NCT04442646

Role of "Asthma School" in Disease Management

Trial Parameters

Condition Asthma
Sponsor Istituti Clinici Scientifici Maugeri SpA
Study Type INTERVENTIONAL
Phase N/A
Enrollment 92
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2019-04-01
Completion 2025-11-15
Interventions
multidisciplinary lessons

Brief Summary

According to the definition provided by the GINA guidelines, asthma is characterized by a variable and reversible limitation of expiratory airflow and by the following symptoms: wheezing, dyspnoea, thoracic constriction and/or cough. The type and the severity of airflow limitation can vary over time (1) depending on external agents, such as physical exercise, polluting agents, climate changes and viral infections. The therapy is mainly based on the use of inhaled corticosteroids and bronchodilators. Patients affected by severe asthma (\~ 10% of total prevalence of asthma and at high risk of exacerbations and/or hospitalization) may not control their symptoms, even if exposed to maximal doses of inhalation therapy.The behavioural sciences can potentially help to find the psychological factors behind scarce adherence and to develop strategies with the aim of improving the interactive processes between patients, medical doctors and health care professionals

Eligibility Criteria

Inclusion Criteria: * Asthma diagnosis according to GINA / ATS guidelines. * Age ≥18 years Exclusion Criteria: •cognitive impairment

Related Trials